LENSAR to Hold Fourth Quarter & Full Year 2020 Financial Results & Bus. Update Conference Call on Wednesday, March 10, 2021
March 03 2021 - 4:05PM
Business Wire
LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a
global medical technology company focused on advanced femtosecond
laser surgical solutions for the treatment of cataracts, today
announced that the Company’s fourth quarter and full year 2020
financial results will be released before market open on Wednesday,
March 10, 2021. LENSAR’s management will host a conference call and
webcast at 8:30 am ET on Wednesday, March 10, 2021 to discuss the
financial results and recent corporate highlights.
To participate by telephone, please dial (833) 312-1363
(Domestic) or (236) 712-2498 (International). The conference ID
number is 1061836. To access the live webcast, please go to the
Investors section of LENSAR’s website at www.lensar.com. Following
the live webcast, an archived version of the call will be available
on the website.
About LENSAR
LENSAR is a commercial-stage medical device company focused on
designing, developing and marketing an advanced femtosecond laser
system for the treatment of cataracts and the management of
pre-existing or surgically induced corneal astigmatism. Its LENSAR
Laser System incorporates a range of proprietary technologies
designed to assist the surgeon in obtaining better visual outcomes,
efficiency and reproducibility by providing advanced imaging,
simplified procedure planning, efficient design and precision.
Forward-looking Statements
This press release contains “forward-looking statements” within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended.. Each of these forward-looking statements involves risks
and uncertainties. Actual results may differ materially from those,
express or implied, in these forward-looking statements. Important
factors that could impair the value of the Company’s assets and
business are disclosed under the heading “Risk Factors” contained
in the Company’s Form 10 Registration Statement, as amended, filed
with the Securities and Exchange Commission. All forward-looking
statements are expressly qualified in their entirety by such
factors. The Company does not undertake any duty to update any
forward-looking statement except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210303005919/en/
Thomas R. Staab, II, CFO ir.contact@lensar.com Lee Roth /
Cameron Radinovic Burns McClellan for LENSAR lroth@burnsmc.com /
cradinovic@burnsmc.com
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Mar 2024 to Apr 2024
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Apr 2023 to Apr 2024